pemazyre
incyte biosciences distribution b.v. - pemigatinib - cholangiocarcinoma - antineoplastická činidla - pemazyre monotherapy is indicated for the treatment of adults with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.
sporanox 10mg/ml perorální roztok
janssen-cilag s.r.o., praha array - 9219 itrakonazol - perorální roztok - 10mg/ml - itrakonazol
turalio
daiichi sankyo europe gmbh - pexidartinib - giant cell tumor of tendon sheath; synovitis, pigmented villonodular - antineoplastická činidla - treatment of tenosynovial giant cell tumour.